Skip to content
Search

Latest Stories

Government monitoring potential impact of Covid-19 on medicine supply

The Department of Health and Social Care (DHSC) said it was evaluating the potential impact of Covid-19 (coronavirus) on the supply of medicines and medical goods.

The government confirmed that there was no current medicine shortage in the UK but directed suppliers to carry out a risk assessment on the impact of the disease on their businesses to relieve potential pressures on the global supply chains.


As an extra precaution, pharma companies have also been asked to retain existing stockpiles of medical supplies, compiled as a contingency measure ahead of Brexit, where possible.

However, the DHSC dismissed the need for the public or the NHS to stockpile, saying it could aggravate problems elsewhere in the supply chain if they emerged.

Health Minister Nicola Blackwood said: "We are not aware of any current medicine shortages linked to this novel coronavirus, but we are putting in place common-sense measures as a precaution to help to ensure the uninterrupted supply of medicines to UK patients.”

The government says it would continually monitor the impact of Covid-19 on the UK supply chain and put in place measure to protect UK patients.

“We have world-class systems in place to prevent supply problems and we are working closely with industry and partners to prevent shortages and ensure the risks to patients are minimised,” the minister added.

More For You

ABPI criticises proposed chances to payment rate for newer branded medicines

DHSC launches an open consultation seeking feedback on the proposed changes to the Statutory Scheme payment rate

Getty Images

Rising payment rate for branded medicines exposes ‘fundamentally broken’ UK market – ABPI

The Association of the British Pharmaceutical Industry (ABPI) has criticised the government’s proposed changes to the Statutory Scheme payment rate for newer branded medicines, warning that it reflects a “fundamentally broken” UK medicines market.

The ‘payment rate’ refers to the amount of revenue pharmaceutical companies must return to the government on their sales of branded medicines to the NHS—an additional charge on top of standard taxes.

Keep ReadingShow less
Man jailed for robbing pharmacy at knifepoint

Daniel Bennett threatened to harm staff unless medication was handed over.

Man jailed for robbing pharmacy at knifepoint

A man who robbed a pharmacy in Winterbourne last year at knifepoint has been sentenced to prison.

Daniel Bennett, 41 of Wedmore Vale in Bedminster, was jailed for six years and nine months, with an extended three-year licence period, after pleading guilty to robbery and possession of a bladed article.

Keep ReadingShow less
NHS England reform: Community pharmacy is missing from the conversation, says Numark

Harry McQuillan, chairman of Numark

Abolition of NHS England – an opportunity for change, says Numark

Numark has welcomed prime minister Keir Starmer’s decision to abolish NHS England but emphasised the need to ensure community pharmacy is not overlooked in the restructuring.

Harry McQuillan, chairman of Numark, described the announcement as “a bold move” that signals a desire to put the NHS "back at the heart of government where it belongs.”

Keep ReadingShow less
national prescribing service for pharmacists

Sadik Al-Hassan MP

Sadik-Al-Hassan: National pharmacy prescribing service “entirely possible”

A national prescribing service for pharmacists could in theory be developed in the next two-three years according to Sadik-Al-Hassan MP.

Speaking at an event organised by PharmaTech in parliament on Wednesday, Hassan said community pharmacists had the skillset to prescribe but a national service would be “limited” by what they are currently allowed to do.

Keep ReadingShow less